Biocartis Group NV reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was EUR 29.62 million compared to EUR 26.77 million a year ago. Net loss was EUR 31.25 million compared to EUR 28.77 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.29 EUR | +1.05% | -.--% | -.--% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-.--% | 29.08M | |
+73.17% | 12.38B | |
-18.74% | 7.92B | |
+16.15% | 7.2B | |
+4.81% | 5.84B | |
+5.99% | 5.07B | |
+27.07% | 4.53B | |
-21.67% | 3.88B | |
-40.82% | 2.23B | |
+1.49% | 2.02B |
- Stock Market
- Equities
- BCART Stock
- News Biocartis Group NV
- Biocartis Group NV Reports Earnings Results for the Half Year Ended June 30, 2023